Patents for A61K 101 - Radioactive non-metals (526)
09/2008
09/03/2008EP1962911A2 Novel imaging agents for fibrosis
08/2008
08/28/2008US20080206134 Radio-opaque hemostatic agents and devices and methods for the delivery thereof
08/13/2008EP1791571B1 Radiofluorinated peptides
07/2008
07/31/2008WO2008091195A1 Novel heteroaryl substituted imidazo [1,2 -a] pyridine derivatives
07/16/2008EP1942950A2 Biodegradable composite for internal local radiotherapy
07/10/2008WO2008083056A2 Ligands for imaging cardiac innervation
07/10/2008WO2008083054A2 Radioactive ligands for cardiac beta1 adrenoreceptor for imaging congestive heart failure
07/02/2008CN101210016A Heterocycle-fused morphinans compounds, preparation method and use thereof
06/2008
06/26/2008WO2008075040A2 Radioactive pet agents for imaging ccr5 in vivo
06/12/2008US20080138282 Radiolabeled Arylsulfonyl Compounds and Uses Thereof
05/2008
05/22/2008US20080118435 Composition comprising low density microspheres
05/21/2008CN101182349A Recombinant octreotide and uses thereof
05/14/2008EP1920786A1 Oral preparation useful in measuring capacity to metabolize pyridine
05/07/2008CN101172162A Methods of [11c]-radiolabelling phenothiazine and phenothiazine-like compounds
05/06/2008US7368474 [18F]-fluorination for use making radiopharmaceuticals for Positron Emission Tomography (PET); reacting a compound of formula 18F-(Linker)-SH with an activated peptide
04/2008
04/30/2008CN101168554A Method for preparing 18F-FLT
04/10/2008WO2007066119A3 Novel imaging agents for fibrosis
04/09/2008CN101157649A 18F-Fallypride automatically synthesizing method
04/09/2008CN101157648A Method for purifying 18F-Fallypride marker precursor compound
04/02/2008CN101153013A Method of producing DL-tyrosine -**N
03/2008
03/26/2008CN101151054A Radiofluorinated peptides
03/18/2008US7344705 Composition comprising low density microspheres
03/05/2008EP1893245A2 Radiolabeled-pegylation of ligands for use as imaging agents
02/2008
02/27/2008CN101130506A Synthesis method of image agent used for diagnosis of progeria dementia
02/20/2008CN101125208A Apatite developer and its positron emitting tomography imaging
02/13/2008CN101121713A Method for preparing 2beta-carbonyl-3beta-(4-chlorobenzo)-8-(2-fluoro[18F]ethyl)demethyltropane by one-step method
02/13/2008CN100368014C Treatment of tumors by administration of growth hormone releasing compounds and their antagonists
01/2008
01/31/2008WO2007052267A3 Biodegradable composite for internal local radiotherapy
01/16/2008CN101104627A 18F-FDG automatization synthetic method and device
01/10/2008WO2008003954A1 Dye imaging agents
12/2007
12/19/2007CN101089020A VIP analog and its radioactive marker and their prepn process
11/2007
11/21/2007CN101074231A [18F] fluoraro-marked purine compound, its production and use
11/01/2007US20070253899 Dual Function Polymer Micelles
10/2007
10/18/2007US20070243134 Receptor Selective Cannabimimetic Aminoalkylindoles
10/17/2007CN100342916C Biodegradable medical material marker and preparation thereof
10/03/2007EP1262490B1 GPib-LIPID BOND CONSTRUCT AND USE THEREOF
09/2007
09/05/2007CN101028525A Use of tumor caryon single-antibody in physical therapeutic tumor as synergist
08/2007
08/23/2007WO2006036269A3 Microspheres capable of binding radioisotopes, optionally comprising metallic microparticles, and methods of use thereof
08/01/2007EP1812115A2 Liposomes enclosing a radionuclide and a cytotoxic agent for combination therapy
08/01/2007CN101007850A Engomphosis and radiolabeled antibodies to human B lymphocyte restricted differentiation antigen
08/01/2007CN101007777A (s)-(-)-5-tributyltin-N-[(1-allyl-2-pyrrolidinyl)methyl]-2,3-dimethoxybenzamide preparation method
07/2007
07/25/2007CN101002952A Contrast medium for gastrointestinal tract
07/11/2007CN1995020A Radioactive iodine-17- allylamino-17-demethoxygeldanamycin and its preparation method
06/2007
06/27/2007CN1985997A Degradable radioactive sponge and its making process
06/20/2007EP1796737A2 Microspheres capable of binding radioisotopes, optionally comprising metallic microparticles, as well as methods of use thereof
06/14/2007WO2006030291A3 Radiofluorinated peptides
06/13/2007CN1321127C Iodine (I)-23-hydroxyl betulinic acid, rpeparation method and application thereof
06/06/2007EP1791571A2 Radiofluorinated peptides
06/06/2007CN1974587A Basic hydrolysis process for preparing 2-fluoro [18F]-2-deoxy-beta-D-glucose in single tube FDG acidic hydrolysis apparatus
05/2007
05/23/2007CN1966140A Chemical synthesizer capable of preparing multiple fluoro-marking agent
05/16/2007CN1962659A 2- fluoro -N,N- dimethyl -2-(6-methyl-2-p-tolylimidazole [1,2-a] pyridine)-3- acetamide compound and its preparation method
05/10/2007WO2007052267A2 Biodegradable composite for internal local radiotherapy
05/09/2007CN1958615A Antibody of anti human CD20 from human resources functionally, and application
05/02/2007EP1778300A1 Personal cleansing composition containing a per-alk(en)yl hydrocarbon material
04/2007
04/18/2007CN1948311A 2-iodine substituted phenyl-6-trifluoro methyl imidazole [1,2-a]-pyridine-3-acetamide compounds and its preparation method
04/05/2007WO2006084030B1 Small-molecule hsp90 inhibitors
02/2007
02/28/2007EP1275645B1 Labeled compounds for measuring the function of the muscarinic acetylcholine nervous system
02/21/2007EP1753467A1 Diagnostic agents for positron emission imaging using radiolabeled halogenated xanthenes and methods for positron emission imaging with radiolabeled halogenated xanthene diagnostic agents
02/14/2007CN1912111A Engomphosis and radiolabeled antibodies to human b lymphocyte restricted differentiation antigen
02/14/2007CN1911952A Preparation technology of 18F labelled positive electron radioactivity tracer precusor
02/14/2007CN1911947A Synthesis technology of 18F labelled positive electron radioactive tracer precusor
02/14/2007CN1299777C Stilbene derivatives and their use for binding and imaging amyloid plaques
01/2007
01/25/2007WO2006084030A3 Small-molecule hsp90 inhibitors
01/25/2007WO2006070290A8 Agents and methods for early diagnosis and monitoring of alzheimer's disease and other neurological disorders
01/17/2007CN1895660A Treatment of tumors by administration of growth hormone releasing compounds and their antagonists
01/10/2007EP1740225A2 Contrast agents for myocardial perfusion imaging
01/04/2007WO2006116629A3 The preparation of molecular imaging probes using click chemistry
01/03/2007CN1887829A Synthesis process of 18F lebeled positive electron radioactive tracer with ionic liquid as phase transfer catalyst
12/2006
12/13/2006EP1729824A2 Phospholipid analogs for diagnosis and treatment of cancer
11/2006
11/22/2006CN1285582C Thioflavin derivatives for alzheimer's disease premortal diagnosis and starch-like protein in vivo image forming and precaution
11/15/2006CN1861201A Medical implant of sodium iodide and its prepn. method
11/02/2006WO2006070290A3 Agents and methods for early diagnosis and monitoring of alzheimer's disease and other neurological disorders
08/2006
08/23/2006CN1270774C Therapeutic application of chimeric and radiolabeled antibodies to human B lymphocyte restricted differentiation antigen for treatment of b cell lymphoma
05/2006
05/31/2006EP1660519A2 Fluorinated carbohydrate conjugates
05/10/2006CN1771058A Microwave method for preparing radiolabelled gallium complexes
04/2006
04/12/2006EP1270017B1 Radiolabeled pyrimidine nucleoside for the diagnosis of tissue-reproductive activity
03/2006
03/22/2006CN1246042C Preparation method of therapy used iodine-125 sealed seed source core
02/2006
02/16/2006US20060034772 Composition comprising low density microspheres
02/15/2006EP1624901A2 Prosthetic groups attached to stannyl polymer in the synthesis of radiopharmaceuticals
02/14/2006US6998107 comprises void containing vapor of volatile liquid perfluorocarbon, combined with aqueous solution to form contrast agent, for oral/rectal administration or injection; for gastrointestinal imaging/tomography
01/2006
01/18/2006EP1615671A1 Microspheres comprising therapeutic and diagnostic radioactive isotopes
01/04/2006EP1612272A2 Novel antiangiogenic peptides, polynucleotides encoding same and methods for inhibiting angiogenesis
07/2005
07/20/2005EP0910571B1 Novel antiangiogenic peptides, polynucleotides encoding same and methods for inhibiting angiogenesis
11/2004
11/11/2004US20040223914 comprises void containing vapor of volatile liquid perfluorocarbon, combined with aqueous solution to form contrast agent, for oral/rectal administration or injection; for gastrointestinal imaging/tomography
08/2004
08/10/2004US6773696 Wherein void comprises vapor of volatile liquid (aliphatic hydrocarbons, chlorofluorocarbons, tetraalkyl silanes, and perfluorocarbons); for computed tomography imaging of the gastrointestinal region
06/2004
06/09/2004CN1152962C Antiangiogenic peptides derived from plasminogen, its coded polynucleotide and method of inhibiting vascularization
03/2004
03/17/2004EP1071684B1 IMIDAZO 1,2-a]PYRIDINES AS PERIPHERAL BENZODIAZEPINE RECEPTOR BINDING AGENTS
08/2003
08/26/2003US6610270 In vivo determination of metabolic function for use in therapy management
03/2003
03/20/2003US20030053953 Wherein void comprises vapor of volatile liquid (aliphatic hydrocarbons, chlorofluorocarbons, tetraalkyl silanes, and perfluorocarbons); for computed tomography imaging of the gastrointestinal region
03/04/2003US6528039 Low density microspheres and their use as contrast agents for computed tomography and in other applications
01/2003
01/15/2003EP1275645A1 Labeled compounds for measuring the function of the muscarinic acetylcholine nervous system
01/02/2003EP1270017A1 Drugs for the diagnosis of tissue-reproductive activity or the treatment of proliferative diseases
12/2002
12/04/2002EP1262490A1 GPib-LIPID BOND CONSTRUCT AND USE THEREOF
04/2002
04/30/2002US6379649 Useful for diagnosis and treatment, including radiotherapy, of disorders that are characterized by an abnormal density of peripheral benzodiazepine receptors; nerve system disporders
09/2001
09/27/2001US20010024639 Administering to a patient a contrast medium comprising a homogenous aqueous suspension of low density polymeric microsphere filled with a gas, scanning the patient using computed tomography imaging to obtain visible image of tissue
09/04/2001US6284219 In vivo determination of metabolic function for use in therapy management
07/2001
07/03/2001CA2107466C Low density microspheres and their use as contrast agents for computed tomography
06/2001
06/26/2001US6251867 Antiangiogenic peptides and methods for inhibiting angiogenesis
04/2001
04/11/2001EP1089765A2 $i(IN VIVO) DETERMINATION OF METABOLIC FUNCTION FOR USE IN THERAPY MANAGEMENT
01/2001
01/31/2001EP1071684A1 IMIDAZO 1,2-a]PYRIDINES AS PERIPHERAL BENZODIAZEPINE RECEPTOR BINDING AGENTS
1 2 3 4 5 6